These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6336817)

  • 1. Amino acid disturbances in type III glycogenosis: differences from type I glycogenosis.
    Slonim AE; Coleman RA; Moses S; Bashan N; Shipp E; Mushlin P
    Metabolism; 1983 Jan; 32(1):70-4. PubMed ID: 6336817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose recycling and production in glycogenosis type I and III: stable isotope technique study.
    Kalderon B; Korman SH; Gutman A; Lapidot A
    Am J Physiol; 1989 Sep; 257(3 Pt 1):E346-53. PubMed ID: 2782400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism.
    Lee PJ; Patel A; Hindmarsh PC; Mowat AP; Leonard JV
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):601-6. PubMed ID: 7634500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular and tubular function in glycogen storage disease.
    Lee PJ; Dalton RN; Shah V; Hindmarsh PC; Leonard JV
    Pediatr Nephrol; 1995 Dec; 9(6):705-10. PubMed ID: 8747109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic ultrasound findings in the glycogen storage diseases.
    Lee P; Mather S; Owens C; Leonard J; Dicks-Mireaux C
    Br J Radiol; 1994 Nov; 67(803):1062-6. PubMed ID: 7820397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal intragastric therapy in type I glycogen storage disease: effect on hormonal and amino acid metabolism.
    Slonim AE; Lacy WW; Terry A; Greene HL; Burr IM
    Metabolism; 1979 Jul; 28(7):707-15. PubMed ID: 286865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrition therapy for hepatic glycogen storage diseases.
    Goldberg T; Slonim AE
    J Am Diet Assoc; 1993 Dec; 93(12):1423-30. PubMed ID: 8245377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of debrancher deficiency myopathy by the use of high-protein nutrition.
    Slonim AE; Weisberg C; Benke P; Evans OB; Burr IM
    Ann Neurol; 1982 Apr; 11(4):420-2. PubMed ID: 7049057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle].
    Wang W; We M; Song HM; Qiu ZQ; Zhang WM; Wu XY; Lu CX; Qi JM; Jing H; Li F
    Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):608-12. PubMed ID: 19951495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX.
    Geberhiwot T; Alger S; McKiernan P; Packard C; Caslake M; Elias E; Cramb R
    J Inherit Metab Dis; 2007 Jun; 30(3):406. PubMed ID: 17407002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen storage diseases in Thai patients: Phramongkutklao Hospital experience.
    Kamolsilp M
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S295-301. PubMed ID: 16858972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate.
    Smit GP; Berger R; Potasnick R; Moses SW; Fernandes J
    Pediatr Res; 1984 Sep; 18(9):879-81. PubMed ID: 6384910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin and glucagon secretion in hepatic glycogenoses.
    Okada S; Seino Y; Kodama H; Yutaka T; Inui K; Ishida M; Yabuuchi H; Seino Y
    Acta Paediatr Scand; 1979 Sep; 68(5):735-8. PubMed ID: 294125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Debranching enzyme activity in leukocytes and glycogen content of erythrocytes in patients with type III glycogenosis].
    Pieniazek D; Pronicka E; Miłoszewska E; Maciejko D; Gruszczyńska B
    Pediatr Pol; 1983 May; 58(5):447-53. PubMed ID: 6226925
    [No Abstract]   [Full Text] [Related]  

  • 16. Fuels, hormones, and liver metabolism at term and during the early postnatal period in the rat.
    Girard JR; Cuendet GS; Marliss EB; Kervran A; Rieutort M; Assan R
    J Clin Invest; 1973 Dec; 52(12):3190-200. PubMed ID: 4750449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuous nocturnal intragastric feeding in glycogenosis type I and III].
    de Parscau L; Guibaud P; Hermier M; François R
    Pediatrie; 1986; 41(3):197-203. PubMed ID: 3095784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lens opacities in glycogenoses type I and III.
    Allegrini D; Autelitano A; Fogagnolo P; De Cillà S; Piozzi E; Mazza M; Paci S; Montanari C; Riva E; Rossetti L
    Can J Ophthalmol; 2015 Dec; 50(6):480-4. PubMed ID: 26651310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some cases of Type III glycogen storage disease.
    Rosenfield EL; Popova IA; Chibisov IV
    Clin Chim Acta; 1976 Mar; 67(2):123-30. PubMed ID: 1061645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of a portable lactate meter in type I glycogen storage disease.
    Saunders AC; Feldman HA; Correia CE; Weinstein DA
    J Inherit Metab Dis; 2005; 28(5):695-701. PubMed ID: 16151900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.